Lithium at 50: Have the neuroprotective effects of this unique cation been overlooked?

Biological Psychiatry

Volumn 46, Issue 7, 1999, Pages 929-940

  Manji, Husseini K ^a   Moore, Gregory J ^a   Chen, Guang ^a  

^a Lab of Molecular Pathophysiology   (United States)

Author keywords

bcl 2; GSK 3 ; Lithium; Manic depressive illness; Neurogeneration; Neuroprotection

Indexed keywords

CASEIN KINASE I; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; NEUROTROPHIC FACTOR; UNCLASSIFIED DRUG;

AFFECTIVE NEUROSIS; ALZHEIMER DISEASE; BIPOLAR DEPRESSION; CORPUS STRIATUM; DISEASE COURSE; HIPPOCAMPUS; HUMAN; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIMANIC AGENTS; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL SURVIVAL; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; LITHIUM CARBONATE; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION;

EID: 0032827466     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00165-1     Document Type: Review

References (70)

1. Adams J.M., Cory S. The Bcl-2 protein family arbiters of cell survival . Science. 281:1998;1322-1326.
2. Baldessarini R.J., Tondo L., Hennen J. Effects of lithium treatment and its discontinuation in bipolar manic-depressive disorders. J Clin Psychiatry. 60:(suppl 2):1999;77-84.
3. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Manji HK (1999): A preliminary investigation of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania. Arch Gen Psychiatry, in press.
4. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 15:1998;44:88-44:97.
5. Bonfanti L., Strettoi E., Chierzi S., Cenni M.C., Liu X.H., Martinou J.-C., et al. Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic mice over expressing bcl-2. J Neurosci. 16:1996;4186-4194.
6. Bruckheimer E.M., Cho S.H., Sarkiss M., Herrmann J., McDonnell T.J. The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotechnol. 62:1998;75-105.
7. Chen D.F., Schneider G.E., Martinou J.C., Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature. 385:1997;434-439.
8. Chen G., Zeng W.Z., Jiang L., Yuan P.X., Zhao J., Manji H.K. The mood stabilizing agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. J Neurochemistry. 72:1999;879-882.
9. Chen R.W., Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression. J Biol Chem. 274:1999;6039-6042.
10. Dale T.C. Signal transduction by the Wnt family of ligands. Biochem J. 329:1998;209-223.
11. D'Mello S.R., Anelli R., Calissano P. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res. 211:1994;332-338.
12. Drevets W.C., Price J.L., Simpson J.R. Jr, Todd R.D., Reich T., Vannier M., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 38:1997;824-827.
13. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry. 54:1997;597-606.
14. Duman RS (1998): Neural plasticity in the pathophysiology and treatment of depression. Abstracts of the American College of Neuropsychopharmacology annual meeting. Puerto Rico.
15. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., et al. Neurogenesis in the adult human hippocampus. Nat Med. 4:1998;1313-1317.
16. Goodwin F.K., Ghaemi N. Bipolar disorder State of the art . Dialogues Clin Neurosci. 1:1999;41-51.
17. Goodwin F.K., Jamison K.R. Manic-Depressive Illness. 1990;Oxford University Press, New York.
18. Gould E., Tanapat P., McEwen B.S., Flugge G., Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci U S A. 95:1998;3168-3171.
19. + protection of cerebellar granule neurons switched to non-depolarizing medium. Eur J Pharmacology. 315:1996;111-114.
20. Hasgekar N.N., Gokhale P.P., Amin M.K., Seshadri R., Lalitha V.S. Lithium inhibits growth in a murine neural precursor cell line. Cell Biol Int. 20:1996;781-786.
21. Hedgepeth C.M., Conrad L.J., Zhang J., Huang H.C., Lee V.M., Klein P.S. Activation of the Wnt signaling pathway A molecular mechanism for lithium action . Dev Biol. 185:1997;82-91.
22. Hong M., Chen D.C., Klein P.S., Lee V.M. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem. 272:1997;25326-25332.
23. Hyman S.E., Nestler E.J. Initiation and adaptation A paradigm for understanding psychotropic drug action . Am J Psychiatry. 153:1996;151-162.
24. Ikonomov O, Manji HK (1999): Molecular mechanisms underlying mood stabilization in manic-depressive illness: The phenotype challenge. Am J Psychiatry, in press.
25. Inouye M, Yamamura H, Nakano A (1995): Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum. J Radiat Res (Tokyo) 36:203-208.
26. Jope R.S., Morrisett R.A., Snead O.C. Characterization of lithium potentiation of pilocarpine induced status epilepticus in rats. Exp Neurol. 91:1986;471-480.
27. Jope R.S. Anti-bipolar therapy Mechanism of action of lithium . Mol Psychiatry. 4:1999;117-128.
28. Ketter T.A., George M.S., Kimbrell T.A., Willis M.W., Benson B.E., Post R.M. Neuroanatomical models and brain imaging studies. Joffe R.T., Young L.T. Bipolar Disorder Biological Models and Their Clinical Application . 1997;179-218 Marcel Dekker, Inc, New York.
29. Klampfer L., Zhang J., Zelenetz A.O., Uchida H., Nimer S.D. The AML1/ETO fusion protein activates transcription of Bcl-2. Proc Natl Acad Sci USA. 26:1996;14059-14064.
30. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A. 93:1996;8455-8459.
31. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2 Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis . Science. 277:1997;559-562.
32. Lawrence M.S., Ho D.Y., Sun G.H., Steinberg G.K., Sapolsky R.M. Over expression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci. 16:1996;486-496.
33. Lenox R.H., Manji H.K. Lithium. Nemeroff C.B., Schatzberg A.F. American Psychiatric Press Textbook of Psychopharmacology. 2nd Edition :1998;379-430 American Psychiatric Press, Washington.
34. Li H., Yuan J. Deciphering the pathways of life and death. Curr Opin Cell Biol. 11:1999;261-266.
35. Li R., Shen Y., El-Mallakh R.S. Lithium protects against ouabain-induced cell death. Lithium. 5:1994;211-216.
36. Liang P., Bauer D., Averboukh L., Warthoe P., Rohrwild M., Muller H., et al. Analysis of altered gene expression by differential display. Methods Enzymol. 254:1995;304-321.
37. Lovestone S., Davis D.R., Webster M.T., Kaech S., Brion J.P., Matus A., et al. Lithium reduces τ phosphorylation Effects in living cells and in neurons at therapeutic concentrations . Biol Psychiatry. 45:1999;995-1003.
38. Lu R., Song L., Jope R.S. Lithium attenuates p53 levels in human neuroblastoma SH-SH-SY5Y cells. Neuroreport. 10:1999;1123-1125.
39. Madiehe A.M., Mampuru L.J., Tyobeka E.M. Induction of apoptosis in HL-60 cells by lithium. Biochem Biophys Res Comm. 209:1995;768-774.
40. Manji HK, Chen G, Hsiao JK, Masana MI, Potter WZ (1999): Regulation of signal transduction pathways by mood stabilizing agents: Implications for the pathophysiology and treatment of bipolar affective disorder. In: Manji HK, Bowden CL, Belmaker RH, editors. Bipolar Medications: Mechanisms of Action, Washington, DC: American Psychiatric Press, in press.
41. Manji HK, Lenox RH (1999): Protein kinase C signaling in the brain: Molecular transduction of mood stabilization in the treatment of bipolar disorder (Ziskind-Somerfeld paper). Biol Psychiatry, in press.
42. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's actions. Arch Gen Psychiatry. 52:1995;531-543.
43. McEwen B.S., Magarinos A.M. Stress effects on morphology and function of the hippocampus. Ann NY Acad Sci. 821:1997;271-284.
44. Merry D.E., Korsmeyer S.J. Bcl-2 gene family in the nervous system. Annu Rev Neurosci. 20:1997;245-267.
45. Munoz-Montano J.R., Moreno F.J., Avila J., Diaz-Nido J. Lithium inhibits Alzheimer's disease-like τ protein phosphorylation in neurons. FEBS Lett. 411:1997;183-188.
46. Nestler E.J. Antidepressant treatments in the 21st century. Biol Psychiatry. 44:1998;526-533.
47. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression cAMP response element-binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
48. Nishimura M., Yu G., Levesque G., Zhang D.M., Ruel L., Chen F., et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med. 5:1999;164-169.
49. Nonaka S., Chuang D.M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport. 9:1998;2081-2084.
50. Nonaka S., Hough C.J., Chuang D.M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A. 95:1998;2642-2647.
51. Nonaka S., Katsube N., Chuang D.M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther. 286:1998;539-547.
52. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 95:1998;13290-13295.
53. Pascual T., Gonzalez J.L. A protective effect of lithium on rat behaviour altered by ibotenic acid lesions of the basal forebrain cholinergic system. Brain Res. 695:1995;289-292.
54. Raghupathi R., Fernandez S.C., Murai H., Trusko S.P., Scott R.W., Nishioka W.K., et al. BCL-2 over expression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab. 18:1998;1259-1269.
55. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann NY Acad Sci. 836:1997;253-268.
56. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry. 45:1999;1085-1098.
57. Reifman A., Wyatt R.J. Lithium A brake in the rising cost of mental illness . Arch Gen Psychiatry. 37:1980;385-388.
58. Sadoul R. Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ. 5:1998;805-815.
59. Shoulson I. Experimental therapeutics of neurodegenerative disorders Unmet needs . Science. 282:1998;1072-1074.
60. Smith M.A., Makino S., Altemus M., Michelson D., Hong S.K., Kvetnansky R., et al. Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci U S A. 92:1995;8788-8792.
61. Soares J.C., Mann J.J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry. 41:1997;86-106.
62. Sparapani M., Virgili M., Ortali F., Contestabile A. Effects of chronic lithium treatment on ornithine decarboxylase induction and excitotoxic neuropathology in the rat. Brain Res. 765:1997;164-168.
63. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 46:1995;531-540.
64. Volonte C., Rukenstein A. Lithium promotes short-term survival of PC12 cells after serum and NGF deprivation. Lithium. 4:1993;211-219.
65. Wang J.F., Young L.T. Differential display PCR reveals increased expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase by lithium. FEBS Lett. 386:1996;225-229.
66. Wang J.F., Young L.T., Li P.P., Warsh J.J. Signal transduction abnormalities in bipolar disorder. Young L.T., Joffe R.T. Bipolar Disorder Biological Models and Their Clinical Applications . 1997;41-79 Marcel Dekker, New York.
67. Willert K., Nusse R. Beta-catenin A key mediator of Wnt signaling . Curr Opin Genet Dev. 8:1998;95-102.
68. Wilson M.R. Apoptosis Unmasking the executioner . Cell Death Differ. 5:1998;646-652.
69. Yang L., Matthews R.T., Schulz J.B., Klockgether T., Liao A.W., Martinou J.C., et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice over expressing bcl-2. J Neurosci. 18:1998;8145-8152.
70. Zhang Z., Hartmann H., Do V.M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., et al. Destabilization of beta catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:1998;698-702.